Tapentadol prolonged release for patients with multiple myeloma suffering from moderate-to-severe cancer pain due to bone disease

CONTEXT: Myeloma bone disease (MBD) is a devastating complication of multiple myeloma that leads to severe pain. OBJECTIVES: The aim of this study was to evaluate the efficacy and tolerability of tapentadol prolonged release (PR) in the management of patients with MBD suffering from moderate-to-seve...

Descripción completa

Detalles Bibliográficos
Autores principales: Coluzzi, Flaminia, Raffa, Robert B, Pergolizzi, Joseph, Rocco, Alessandra, Locarini, Pamela, Cenfra, Natalia, Cimino, Giuseppe, Mattia, Consalvo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431495/
https://www.ncbi.nlm.nih.gov/pubmed/26064064
http://dx.doi.org/10.2147/JPR.S83490

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431495/
https://www.ncbi.nlm.nih.gov/pubmed/26064064
http://dx.doi.org/10.2147/JPR.S83490

Ejemplares similares